Results
|
341021.
|
Efficacy and safety of a two-drug direct-acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6. [electronic resource] by
- Lawitz, Eric
- Gane, Edward
- Feld, Jordan J
- Buti, Maria
- Foster, Graham R
- Rabinovitz, Mordechai
- Burnevich, Eduard
- Katchman, Helena
- Tomasiewicz, Krzysztof
- Lahser, Fred
- Jackson, Beth
- Shaughnessy, Melissa
- Klopfer, Stephanie
- Yeh, Wendy W
- Robertson, Michael N
- Hanna, George J
- Barr, Eliav
- Platt, Heather L
Producer: 20200724
In:
Journal of viral hepatitis vol. 26
Availability: No items available.
|
|
341022.
|
|
|
341023.
|
|
|
341024.
|
|
|
341025.
|
|
|
341026.
|
|
|
341027.
|
|
|
341028.
|
|
|
341029.
|
|
|
341030.
|
|
|
341031.
|
|
|
341032.
|
|
|
341033.
|
|
|
341034.
|
|
|
341035.
|
|
|
341036.
|
|
|
341037.
|
|
|
341038.
|
|
|
341039.
|
|
|
341040.
|
|